(Q51392424)

English

Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs.

scientific article published on 4 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Shin Taniguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Junnosuke Ryu

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Masayuki Seki

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Takanobu Sumino

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Yasuaki Tokuhashi

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Mariko Esumi

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

publication date

4 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Journal of Orthopaedic Research

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

30

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

673-678

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OA.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Osteoarthritis cartilage histopathology: grading and staging.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Glucosamine HCl reduces equine articular cartilage degradation in explant culture

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.22003

21 January 2018

Identifiers

10.1002/JOR.22003

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22058013

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51392424&oldid=1563438572"